Jane Street’s Terns Pharmaceuticals TERN Stock Holding History

Jane Street’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$381K	Sell	7,231 -81,606	-92%	-$3.35M	﹤0.01%	8664
2025 Q4	$3.59M	Buy	88,837 +24,589	+38%	+$568K	﹤0.01%	3747
2025 Q3	$483K	Buy	+64,248	New	+$410K	﹤0.01%	7951
2025 Q1	–	Sell	-36,679	Closed	-$150K	–	10593
2024 Q4	$203K	Sell	36,679 -84,914	-70%	-$575K	﹤0.01%	8384
2024 Q3	$1.01M	Sell	121,593 -21,739	-15%	-$179K	﹤0.01%	5858
2024 Q2	$976K	Buy	143,332 +95,680	+201%	+$580K	﹤0.01%	5822
2024 Q1	$313K	Sell	47,652 -16,801	-26%	-$110K	﹤0.01%	7497
2023 Q4	$418K	Buy	+64,453	New	+$341K	﹤0.01%	7070
2023 Q3	–	Sell	-24,178	Closed	-$153K	–	9375
2023 Q2	$212K	Sell	24,178 -125,183	-84%	-$1.46M	﹤0.01%	7618
2023 Q1	$1.77M	Buy	149,361 +127,854	+594%	+$1.22M	﹤0.01%	4029
2022 Q4	$219K	Buy	21,507 +8,252	+62%	+$54.9K	﹤0.01%	7530
2022 Q3	$78K	Buy	+13,255	New	+$49.3K	﹤0.01%	8762
2021 Q3	–	Sell	-11,973	Closed	-$147K	–	10715
2021 Q2	$147K	Buy	+11,973	New	+$204K	﹤0.01%	9057

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Jane Street's TERN Position: Q1 2026 in Review

Jane Street reduced its Terns Pharmaceuticals (TERN) stake by 92% in Q1 2026, selling an estimated $3.35M and leaving 7,231 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #8664.

Jane Street first reported a position in TERN in Q2 2021 and has held it in 13 quarters since. The position peaked at $3.59M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Jane Street held 7,231 shares of Terns Pharmaceuticals worth $381K as of Q1 2026.
Jane Street sold 81,606 Terns Pharmaceuticals shares in Q1 2026, an estimated $3.35M.
Terns Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8664 holding.
Jane Street first reported a position in Terns Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
Jane Street's Terns Pharmaceuticals position peaked at $3.59M in Q4 2025.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.